Neovasc Inc. regained compliance with the Nasdaq Stock Market's $35 million minimum market value listing requirement.
The Canadian specialty medical device manufacturer received the noncompliance notice in March.
Meanwhile, Neovasc has until July 2 to regain compliance with the exchange's minimum bid price requirement.
